<?xml version="1.0" encoding="UTF-8"?>
<p>Various approaches were employed to investigate whether and how such drugs inhibit hemozoin crystallization (
 <xref rid="r9" ref-type="bibr">9</xref>, 
 <xref rid="r18" ref-type="bibr">18</xref>, 
 <xref rid="r19" ref-type="bibr">19</xref>). In vitro studies monitored crystallization of synthetic hemozoin in the presence of drug molecules, whose affinity to the crystal surface and inhibition of crystallization was tested, but in media different from that of the parasitic digestive vacuole (
 <xref rid="r9" ref-type="bibr">9</xref>, 
 <xref rid="r20" ref-type="bibr">20</xref>, 
 <xref rid="r21" ref-type="bibr">21</xref>). A more direct mode of investigation involved localization of the drug ferroquine within the malaria parasite itself (
 <xref rid="r22" ref-type="bibr">22</xref>), albeit in a dried red blood cell.
</p>
